Related Experiment Videos
Cell-mediated immune response in rubella infections
Reviews of Infectious Diseases
|March 1, 1985
Summary
Cell-mediated immunity to rubella is assessed by lymphocyte response to antigen. Natural infection yields a strong response, while vaccination provides a weaker, yet detectable, cellular immunity crucial for immune status determination.
Area of Science:
- Immunology
- Virology
- Cellular Biology
Background:
- Rubella virus infection confers immunity, but the characteristics of the cellular immune response differ between natural infection and vaccination.
- Congenital rubella infection's impact on lymphocyte response is influenced by gestational age at infection.
- Assessing rubella immunity is critical, especially in pregnant women with unknown infection history.
Purpose of the Study:
- To evaluate the cell-mediated immune response to rubella antigen in different populations.
- To compare lymphocyte responsiveness after natural rubella infection versus vaccination.
- To explore the utility of cell-mediated immunity assays for determining rubella immune status.
Main Methods:
- Cultures of lymphocytes were stimulated with purified rubella antigen.
- Lymphocyte responses were measured in individuals with natural rubella infection, vaccination, congenital infection, and in susceptible individuals.
- Cell-mediated immune response was assessed in women exposed to rubella during pregnancy.
Main Results:
- Lymphocytes from rubella-susceptible individuals showed no response to rubella antigen.
- Strong lymphocyte responses were observed in naturally infected individuals.
- Vaccinees exhibited a weaker, but significant, cell-mediated immune response compared to naturally infected individuals.
- Congenitally infected children's lymphocyte response varied with gestational age at infection.
Conclusions:
- Cell-mediated immunity, assessed via lymphocyte response to rubella antigen, provides a valuable measure of immunity.
- The booster response observed after vaccination or revaccination is useful for identifying immune status in pregnant women with unknown rubella history and negative humoral immunity.